Skip to main content
. 2016 Sep 25;22(3):359–365. doi: 10.3350/cmh.2016.0033

Table 4.

Comparison of clinical characteristics for three patients with detectable plasma GPC3 levels in both ELISA assays

Patient Age Etiology Cirrhosis BCLC stage Tumor number Max tumor size (cm) GPC3 (ng/mL)
Assay 1 Assay 2
A 66 HBV Yes A 1 3.0 0.18 83.16
B 62 HBV Yes A 2 1.7 1.11 14.79
C 51 HBV Yes C 1 4.6 0.78 10.59

ELISA, enzyme-linked immunosorbent assay; BCLC, barcelona clinic liver cancer; GPC3, glypican-3; HBV, hepatitis B virus.